Back to Connor, Clark & Lunn Investment Management Ltd. Connor, Clark & Lunn Investment Management Ltd.

ZNTLZNTL
Showing 8 of 10 quarters

Position history for Connor, Clark & Lunn Investment Management Ltd.Connor, Clark & Lunn Investment Management Ltd.'s holdings in ZENTALIS PHARMACEUTICALS INC

Connor, Clark & Lunn Investment Management Ltd. holds 758,033 shares of ZNTL (ZENTALIS PHARMACEUTICALS INC), worth $3.7M as of 2026-Q2. The position was decreased (-4.3% shares). ZNTL represents 0.0% of Connor, Clark & Lunn Investment Management Ltd.'s portfolio.

Current Value

$3.7M

Current Shares

758,033

Total Value Change

+$2.8M

Total Shares Change

+528,895

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
758,033
-4.3%
$3.7M0.0%$4.85
0
2026-Q1
Increased
792,001
+0.6%
$1.9M0.0%$2.38
26
2025-Q4
Increased
787,055
+106.7%
$1.1M0.0%$1.33
41
2025-Q3
Increased
380,822
+21.0%
$575,0410.0%$1.49
29
2025-Q2
Decreased
314,845
-12.8%
$365,2200.0%$1.18
0
2025-Q1
Increased
361,236
+4.7%
$574,3650.0%$1.81
25
2024-Q4
Increased
345,039
+50.6%
$1M0.0%$2.92
35
2024-Q3
Increased
229,138
+126.3%
$843,2280.0%$3.75
40

Other major holders of ZNTL: FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used